NYSE : CNMD
CONMED Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 44.29 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.32B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.32B |
| Enterprise Value | 2.09B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 29.80M |
| Shares Outstanding | 29.80M |
| Shares Change (YoY) | -2.14% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 114.76% |
| Float | 29.51M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 18.39 |
| Forward PE | 9.57 |
| PS Ratio | 0.96 |
| Forward PS | 0.94 |
| PB Ratio | 1.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.95 |
| P/OCF Ratio | 9.02 |
| PEG Ratio | 1.88 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 28.43 |
| EV / Sales | 1.52 |
| EV / EBITDA | 9.71 |
| EV / EBIT | 14.89 |
| EV / FCF | 15.73 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.49 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 3.61 |
| Debt / FCF | 6.15 |
| Interest Coverage | 3.80 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 7.10% |
| Return on Assets (ROA) | 3.79% |
| Return on Invested Capital (ROIC) | 5.35% |
| Return on Capital Employed (ROCE) | 7.60% |
| Weighted Average Cost of Capital (WACC) | 7.04% |
| Revenue Per Employee | $351,099 |
| Profits Per Employee | $18,829 |
| Employee Count | 3,900 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.70 |
Taxes
| Measure | Value |
|---|
| Income Tax | 31.53M |
| Effective Tax Rate | 30.04% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -5.18% |
| 50-Day Moving Average | 47.08 |
| 200-Day Moving Average | 41.41 |
| Relative Strength Index (RSI) | 40.60 |
| Average Volume (20 Days) | 437,621 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 846,967 |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.84% |
| Short % of Float | 2.87% |
| Short Ratio (days to cover) | 4.85 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.37B |
| Gross Profit | 750.24M |
| Operating Income | 140.25M |
| Pretax Income | 104.96M |
| Net Income | 73.43M |
| EBITDA | 214.97M |
| EBIT | 140.25M |
| Earnings Per Share (EPS) | $2.41 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 47.97M |
| Total Debt | 815.87M |
| Net Cash | -767.89M |
| Net Cash Per Share | -$25.77 |
| Equity (Book Value) | 1.06B |
| Book Value Per Share | 35.49 |
| Working Capital | 223.08M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 146.31M |
| Capital Expenditures | -13.62M |
| Depreciation & Amortization | 74.72M |
| Net Borrowing | -32.80M |
| Free Cash Flow | 132.69M |
| FCF Per Share | $4.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.79% |
| Operating Margin | 10.24% |
| Pretax Margin | 7.67% |
| Profit Margin | 5.36% |
| EBITDA Margin | 15.70% |
| EBIT Margin | 10.24% |
| FCF Margin | 9.69% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.14% |
| Shareholder Yield | 2.14% |
| Earnings Yield | 5.44% |
| FCF Yield | 10.05% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $46.83 |
| Price Target Difference | 5.74% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 3.07% |
| EPS Growth Forecast (3Y) | 4.98% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 10, 2001 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.91 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |